Enhancing the Capacity and Capability of Human Food and Environmental Testing Laboratory at the Texas Department of State Health Services: Radiochemistry Food Defense

项目摘要 学科C放射化学，轨道1食品防御 根据这项合作协议，德克萨斯州卫生部的主要目标是 实验室服务科（LSS）放射化学组负责确保人类 在德克萨斯州生产和/或分销的食品和人类食品是安全的， 是否存在放射性污染，并确定放射性核素的身份 存在于人体样本中。数据将用于描述食品污染的程度， 发现趋势计算摄入量DSHS LSS计划参与以下活动： 为实现这些目标而开展的具体活动。 1.分类数据，以确定是否需要进一步分析; 2.利用结果确定污染是否远高于或远低于监管限值; 3.参与FDA要求的分诊演习和/或监测活动，以支持和 保持准备状态。 4.参加国家安全事件演习，如果可以的话。 5.参加并通过本项目下所做工作的年度能力测试（PT）。 6.通过参加预定的电话、会议和FERN来保持FERN会员资格 活动 7.放射化学小组的两名工作人员将出席森林问题实况调查团的年度面对面会议。 8.维护与本项目相关的测试所需的设施和人员。 9.使用FDA标准化验证方法，紧急情况除外。 10.提供通过以下方式收集和分析的所有样本的详细季度总结： FERN网站，这是FERN参与者的正常程序。 11.遵循最佳实践建议，以获得适当的采样和实验室数据 记录并使用FDA表格431或同等文件进行样品分析。 12.在一个工作日内通知FDA项目经理和技术负责人， 假定阳性或“不能排除”（CRO）样本，并提交完整的实验室 任何确认的阳性或违规样本的包装在最终的三个工作日内。 13.与FDA保持有效的20.88协议，并参与至少一项FDA要求的 如果可能的话，年度任务。 1

Project Summary Discipline C Radiochemistry, Track 1 Food Defense Under this cooperative agreement, the primary goals for the Texas Department of State Health Services (DSHS), Laboratory Service Section (LSS) Radiochemistry Group are to ensure human food and human food products made and/or distributed in Texas are safe, determine the presence or absence of radioactive contamination, and determine the identities of radionuclides present in human samples. Data will be used to characterize the extent of food contamination, spotting trends, and calculating intakes. The DSHS LSS plans participation in the following specific aims and activities to achieve these goals. 1. Triage data to determine whether further analysis is needed; 2. Utilize results to determine if contamination is well above or well below regulatory limits; 3. Participate in FDA-requested triage exercises, and/or surveillance activities to support and maintain readiness. 4. Participate in national security event exercises, as available. 5. Participate in and pass annual proficiency test (PT) for work performed under this project. 6. Maintain FERN membership by participating in scheduled calls, meetings, and FERN activities. 7. Two Radiochemistry Group staff will attend the annual LFFM Face-to-Face meeting. 8. Maintain facilities and personnel necessary for testing related to this project. 9. Use FDA standardized validated methods, with the exception of emergency situations. 10. Provide a detailed quarterly summary of all samples collected and analyzed through the FERN website, as is normal procedure for FERN participants. 11. Follow best practices recommendations for proper sampling and laboratory data documentation and use FDA Form 431, or equivalent, for analytical for samples. 12. Notify the FDA project manager and the technical lead within one business day of any presumptive positive or “cannot rule out” (CRO) samples and submit the full laboratory package for any confirmed positive or violative sample within three business days of final. 13. Maintain a valid 20.88 agreement with FDA and participate in at least one FDA-requested annual assignment, if possible. 1